Participants 61 129 4
metastatic or recurrent squamous cell carcinoma of the head and neck
Participants 381 529 7
recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients, whose disease has progressed after platinum-containing therapy
Participants 623 635 5
124 patients
Participants 967 1003 5
A total of 121 patients were treated
